Coherus Biosciences Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7.7M | 572 | 75.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $925,775 | 300 | 9.1% |
| Consulting Fee | $805,950 | 237 | 7.9% |
| Food and Beverage | $354,876 | 11,973 | 3.5% |
| Honoraria | $239,468 | 125 | 2.3% |
| Travel and Lodging | $150,859 | 587 | 1.5% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| CHS170107 | $1.7M | 0 | 16 |
| CHS14209 | $1.6M | 0 | 4 |
| CHS-131-016 | $1.0M | 0 | 1 |
| SRF114-101 | $787,395 | 0 | 57 |
| A Randomized Phase 2 Trial of Atezolizumab and Bevacizumab in Combination With SRF388 or Placebo in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma | $643,935 | 0 | 188 |
| CHS601 | $533,299 | 0 | 81 |
| A Phase 1/1b Study of CHS-388 (formerly known as SRF388) in Patients with Advanced Solid Tumors | $363,371 | 0 | 206 |
| 305 | $312,095 | 0 | 1 |
| CHS-1701-08 | $286,500 | 0 | 4 |
| CHS-131 | $220,086 | 0 | 1 |
| An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca (POEM) | $207,775 | 0 | 1 |
| CHS-1701-09 | $59,249 | 0 | 12 |
Payments by Medical Specialty
Top Paid Doctors — Page 3
| Doctor | Specialty | Location | Total | 2021 |
|---|---|---|---|---|
| Joseph Readling, Md, MD | Hematology & Oncology | Binghamton, NY | $9,022 | $0 |
| Dr. Brian Harvey, Md, MD | Internal Medicine | Annapolis, MD | $8,750 | $0 |
| Kathleen Clifford, Np, NP | Nurse Practitioner | Boise, ID | $8,727 | $0 |
| Dr. Jong Chul Park, M.d, M.D | Internal Medicine | Boston, MA | $8,350 | $0 |
| Francis Arena, Md, MD | Internal Medicine | Lake Success, NY | $8,296 | $0 |
| Dr. Andrea Stebel, M.d, M.D | Hematology & Oncology | Newport Beach, CA | $8,266 | $0 |
| Dr. Vijay Gunuganti, M.d, M.D | Medical Oncology | San Antonio, TX | $8,254 | $0 |
| Dr. Jonathan Jonisch, Md, MD | Ophthalmology | Great Neck, NY | $7,936 | $0 |
| Raja Mudad, Md, MD | Hematology & Oncology | Miami, FL | $7,174 | $0 |
| Carl Regillo, Md, MD | Ophthalmology | Plymouth Meeting, PA | $7,113 | $0 |
| Sreekanth Reddy, Md, MD | Hematology & Oncology | Vidalia, GA | $7,060 | $0 |
| Dr. Vladimir Gotlieb, Md, MD | Hematology & Oncology | Forest Hills, NY | $6,991 | $0 |
| Robert Haddad, Md, MD | Medical Oncology | Boston, MA | $6,938 | $0 |
| Dr. Ashkan Abbey, M.d, M.D | Ophthalmology | Dallas, TX | $6,935 | $0 |
| Dr. John Yu, M.d, M.D | Neurological Surgery | Los Angeles, CA | $6,923 | $0 |
| Dr. Mohsen Arani, Md, MD | Hematology & Oncology | The Woodlands, TX | $6,608 | $0 |
| Barbara Burtness, M.d, M.D | Interventional Cardiology | New Haven, CT | $6,375 | $0 |
| Priya Vakharia, Md, MD | Retina Specialist | Palm Harbor, FL | $6,336 | $0 |
| Julie Plantamura, Anpc, ANPC | Adult Health | Port Jefferson Station, NY | $6,310 | $0 |
| Deepak Sambhara, M.d, M.D | Ophthalmology | Wausau, WI | $6,305 | $0 |
| Dr. Jeremy Wolfe, Md, MD | Ophthalmology | Royal Oak, MI | $6,305 | $0 |
| Dr. Gaurav Shah, Md, MD | Retina Specialist | San Francisco, CA | $6,305 | $0 |
| Jeffrey Gross, M.d, M.D | Ophthalmology | Columbia, SC | $6,089 | $0 |
| Willis Maddrey, Md, MD | Hepatology | Dallas, TX | $6,013 | $0 |
| Haresh Jhangiani, M.d, M.D | Specialist | Fountain Valley, CA | $6,011 | $0 |
About Coherus Biosciences Inc.
Coherus Biosciences Inc. has made $10.2M in payments to 5,259 healthcare providers, recorded across 13,794 transactions in the CMS Open Payments database. In 2024, the company paid $2.2M. The top product by payment volume is Udenyca ($2.7M).
Payments were distributed across 111 medical specialties. The top specialty by payment amount is Ophthalmology ($461,034 to 691 doctors).
Payment categories include: Food & Beverage ($354,876), Consulting ($805,950), Research ($7.7M), Travel & Lodging ($150,859).
Coherus Biosciences Inc. is associated with 3 products in the CMS Open Payments database.